| 1 |
Pillaiyar_2020 |
A medicinal chemistry perspective of drug repositioning: Recent advances and challenges in drug discovery |
Pillaiyar, Thanigaimalai; Meenakshisundaram, Sangeetha; Manickam, Manoj; Sankaranarayanan, Murugesan |
2020 |
2020-04-02 |
PMC |
N |
|
|
10.1016/j.ejmech.2020.112275 |
icyut3xa |
0.944343 |
Dove_2004, Li_C_2019, Mercorelli_2018 |
Zhang_2015, Liu_A_2012, Chattopadhyay_2009, Chattopadhyay_2015 |
| 2 |
Singer_2016 |
Chapter Four Clinical Perspectives on Targeting Therapies for Personalized Medicine |
Singer, Donald R.J.; Zaïr, Zoulikha M. |
2016 |
2016-12-31 |
PMC |
N |
PMC7102676 |
26827603.0 |
10.1016/bs.apcsb.2015.11.003 |
92xazjkb |
0.849051 |
Dove_2004 |
Pillaiyar_2020 |
| 3 |
Kumar_2019 |
Exploring the new horizons of drug repurposing: A vital tool for turning hard work into smart work |
Kumar, Rajesh; Harilal, Seetha; Gupta, Sheeba Varghese; Jose, Jobin; Thomas Parambi, Della Grace; Uddin, Md. Sahab; Shah, Muhammad Ajmal; Mathew, Bijo |
2019 |
2019-11-15 |
PMC |
N |
PMC7127402 |
31421629.0 |
10.1016/j.ejmech.2019.111602 |
1b3x7p6u |
0.728734 |
Dove_2004 |
Pillaiyar_2020, Bolken_2008, van_der_Kooy_2013 |
| 4 |
Dey_T_2018 |
Proteases and Their Inhibitors in Chronic Obstructive Pulmonary Disease |
Dey, Tapan; Kalita, Jatin; Weldon, Sinéad; Taggart, Clifford C. |
2018 |
2018-08-28 |
COMM-USE |
N |
PMC6162857 |
30154365.0 |
10.3390/jcm7090244 |
nycqanco |
0.693309 |
|
|
| 5 |
Saglio_2014 |
The time is now: moving toward virus-specific T cells after allogeneic hematopoietic stem cell transplantation as the standard of care |
Saglio, Francesco; Hanley, Patrick J.; Bollard, Catherine M. |
2014 |
2014-02-28 |
PMC |
N |
PMC3928596 |
24438896.0 |
10.1016/j.jcyt.2013.11.010 |
3rbjwjxu |
0.687183 |
|
|
| 6 |
Aggarwal_2019 |
Drug repurposing for breast cancer therapy: Old weapon for new battle |
Aggarwal, Sadhna; Verma, Sumit Singh; Aggarwal, Sumit; Gupta, Subash Chandra |
2019 |
2019-09-21 |
PMC |
N |
|
31550502.0 |
10.1016/j.semcancer.2019.09.012 |
r5p5helx |
0.680950 |
Dove_2004, Li_C_2019 |
Pillaiyar_2020, Chen_2019, Peyclit_2019 |
| 7 |
Beigel_2010 |
ANTIVIRAL COMPOUNDS IN THE PIPELINE TO TACKLE H1N1 INFLUENZA INFECTION |
Beigel, J.H. |
2010 |
2010-01-01 |
PMC |
N |
PMC3129656 |
21738286.0 |
10.1358/dof.2010.035.05.1487081 |
zhzunz4v |
0.672903 |
|
Martínez_2008, De_Clercq_2007, D’Alessandro_2020 |
| 8 |
Senanayake_2020 |
Drug repurposing strategies for COVID-19 |
Senanayake, Suranga L |
2020 |
2020-03-25 |
NONCOMM |
Y |
PMC7117595 |
|
10.4155/fdd-2020-0010 |
nbjili3v |
0.671840 |
Dove_2004 |
García-Serradilla_2019, Peyclit_2019, Schor_2018 |
| 9 |
Sweiti_2017 |
Repurposed Therapeutic Agents Targeting the Ebola Virus: A Systematic Review |
Sweiti, Hussein; Ekwunife, Obinna; Jaschinski, Thomas; Lhachimi, Stefan K. |
2017 |
2017-02-02 |
None |
N |
PMC5522984 |
28761574.0 |
10.1016/j.curtheres.2017.01.007 |
8dbenul1 |
0.636654 |
Beigel_2010, Lythgoe_2020 |
|
| 10 |
Mercorelli_2018 |
Drug Repurposing for Viral Infectious Diseases: How Far Are We? |
Mercorelli, Beatrice; Palù, Giorgio; Loregian, Arianna |
2018 |
2018-10-31 |
None |
N |
PMC7126639 |
29759926.0 |
10.1016/j.tim.2018.04.004 |
7jhjlxtf |
0.624639 |
Dove_2004, Li_C_2019, Pizzorno_2019, Martínez_2008 |
Pizzorno_2019, Martínez_2008, Schor_2018, D’Alessandro_2020 |
| 11 |
Li_C_2019 |
Repurposing host-based therapeutics to control coronavirus and influenza virus |
Li, Cui-Cui; Wang, Xiao-Jia; Wang, Hwa-Chain Robert |
2019 |
2019-03-31 |
PMC |
N |
PMC7108273 |
30711575.0 |
10.1016/j.drudis.2019.01.018 |
r4snyxr9 |
0.623237 |
Dove_2004, Zhu_J_2015, Wisskirchen_2014 |
Schor_2018, Pizzorno_2019, Martínez_2008, Lee_C_2019 |
| 12 |
Van_Norman_2018 |
Expanding Patient Access to Investigational New Drugs: Overview of Intermediate and Widespread Treatment Investigational New Drugs, and Emergency Authorization in Public Health Emergencies |
Van Norman, Gail A. |
2018 |
2018-06-25 |
None |
N |
PMC6058931 |
30062226.0 |
10.1016/j.jacbts.2018.02.001 |
58ta20fg |
0.622204 |
Dove_2004 |
|
| 13 |
Balicer_2005 |
Cost-Benefit of Stockpiling Drugs for Influenza Pandemic |
Balicer, Ran D.; Huerta, Michael; Davidovitch, Nadav; Grotto, Itamar |
2005 |
2005-08-23 |
PMC |
N |
PMC3320484 |
16102319.0 |
10.3201/eid1108.041156 |
ppnxc32f |
0.599833 |
Dove_2004 |
Sperber_1987, Pizzorno_2019 |
| 14 |
Fang_2019 |
Synthetic approaches and pharmaceutical applications of chloro-containing molecules for drug discovery: A critical review |
Fang, Wan-Yin; Ravindar, L.; Rakesh, K.P.; Manukumar, H.M.; Shantharam, C.S.; Alharbi, Njud S.; Qin, Hua-Li |
2019 |
2019-07-01 |
PMC |
N |
PMC7111421 |
30995567.0 |
10.1016/j.ejmech.2019.03.063 |
j5urhxw2 |
0.593212 |
Dove_2004 |
Pillaiyar_2020, Yasuhara-Bell_2010, Zhang_2015 |
| 15 |
van_der_Merwe_2012 |
Challenge models to assess new therapies in chronic obstructive pulmonary disease |
van der Merwe, René; Molfino, Nestor A |
2012 |
2012-09-13 |
PMC |
N |
PMC3459659 |
23055710.0 |
10.2147/copd.s30664 |
wurzy88k |
0.592593 |
|
Dey_T_2018 |
| 16 |
Andrade_2013 |
Nanotechnology and pulmonary delivery to overcome resistance in infectious diseases |
Andrade, Fernanda; Rafael, Diana; Videira, Mafalda; Ferreira, Domingos; Sosnik, Alejandro; Sarmento, Bruno |
2013 |
2013-11-30 |
PMC |
N |
PMC7103277 |
23932923.0 |
10.1016/j.addr.2013.07.020 |
0t3fdpj5 |
0.566841 |
Dove_2004 |
Al‐Bari_2017 |
| 17 |
Zumla_2016 |
Host-directed therapies for infectious diseases: current status, recent progress, and future prospects |
Zumla, Alimuddin; Rao, Martin; Wallis, Robert S; Kaufmann, Stefan H E; Rustomjee, Roxana; Mwaba, Peter; Vilaplana, Cris; Yeboah-Manu, Dorothy; Chakaya, Jeremiah; Ippolito, Giuseppe; Azhar, Esam; Hoelscher, Michael; Maeurer, Markus |
2016 |
2016-04-30 |
None |
N |
PMC7164794 |
27036359.0 |
10.1016/s1473-3099(16)00078-5 |
c7klnns9 |
0.555777 |
Wisskirchen_2014 |
Kaufmann_2017, Zilbermintz_2015, Schor_2018 |
| 18 |
Peyclit_2019 |
Drug Repurposing to Fight Colistin and Carbapenem-Resistant Bacteria |
Peyclit, Lucie; Baron, Sophie Alexandra; Rolain, Jean-Marc |
2019 |
2019-06-11 |
COMM-USE |
N |
PMC6579884 |
31245302.0 |
10.3389/fcimb.2019.00193 |
4h73lukj |
0.540200 |
Dove_2004, Mercorelli_2018 |
Wang_2018, Wu_H_2016 |
| 19 |
van_der_Kooy_2013 |
Reverse Pharmacology and Drug Discovery: Artemisia annua and Its Anti-HIV Activity |
van der Kooy, Frank |
2013 |
2013-11-27 |
PMC |
N |
PMC7124147 |
|
10.1007/978-3-642-41027-7_14 |
rhg5pbsq |
0.538639 |
|
Bekut_2018 |
| 20 |
Dyall_2017 |
Middle East Respiratory Syndrome and Severe Acute Respiratory Syndrome: Current Therapeutic Options and Potential Targets for Novel Therapies |
Dyall, Julie; Gross, Robin; Kindrachuk, Jason; Johnson, Reed F.; Olinger, Gene G.; Hensley, Lisa E.; Frieman, Matthew B.; Jahrling, Peter B. |
2017 |
2017-12-23 |
None |
N |
PMC5733787 |
29143192.0 |
10.1007/s40265-017-0830-1 |
hyihoelf |
0.534710 |
Dove_2004, Beigel_2010 |
Al-Tawfiq_2016, Mustafa_2018, Omrani_2015 |
| 21 |
Bumcrot_2006 |
RNAi therapeutics: a potential new class of pharmaceutical drugs |
Bumcrot, David; Manoharan, Muthiah; Koteliansky, Victor; Sah, Dinah W Y |
2006 |
2006-01-01 |
PMC |
N |
PMC7097247 |
17108989.0 |
10.1038/nchembio839 |
muq3eq9v |
0.519254 |
|
Martínez_2008 |
| 22 |
Arruebo_2011 |
Assessment of the Evolution of Cancer Treatment Therapies |
Arruebo, Manuel; Vilaboa, Nuria; Sáez-Gutierrez, Berta; Lambea, Julio; Tres, Alejandro; Valladares, Mónica; González-Fernández, África |
2011 |
2011-08-12 |
COMM-USE |
N |
PMC3759197 |
24212956.0 |
10.3390/cancers3033279 |
9g8rwsm1 |
0.518395 |
|
Chen_2019, Harrington_2010 |
| 23 |
Amirian_2020 |
Current knowledge about the antivirals remdesivir (GS-5734) and GS-441524 as therapeutic options for coronaviruses |
Amirian, E. Susan; Levy, Julie K. |
2020 |
2020-06-30 |
PMC |
Y |
|
|
10.1016/j.onehlt.2020.100128 |
95fc828i |
0.518075 |
Dove_2004 |
Zhu_X_2015 |
| 24 |
Kinast_2019 |
Hepatitis E Virus Drug Development |
Kinast, Volker; Burkard, Thomas L; Todt, Daniel; Steinmann, Eike |
2019 |
2019-05-28 |
COMM-USE |
N |
PMC6631701 |
31141919.0 |
10.3390/v11060485 |
5rsk6g7l |
0.517539 |
Jerome_2005 |
Debing_2014 |
| 25 |
Powell_2017 |
5.20 Antiviral Drugs for Acute Infections |
Powell, K.L.; Thomas, E.; Cockerill, G.S. |
2017 |
2017-12-31 |
PMC |
N |
PMC7149606 |
|
10.1016/b978-0-12-409547-2.12408-4 |
50hivtvi |
0.517118 |
Jerome_2005 |
D’Alessandro_2020, Martínez_2008, Mercorelli_2018 |
| 26 |
Lythgoe_2020 |
Ongoing Clinical Trials for the Management of the COVID-19 Pandemic |
Lythgoe, Mark P.; Middleton, Paul |
2020 |
2020-04-09 |
PMC |
Y |
|
|
10.1016/j.tips.2020.03.006 |
52f5pdw2 |
0.513757 |
Dove_2004 |
|
| 27 |
Flego_2013 |
Clinical development of monoclonal antibody-based drugs in HIV and HCV diseases |
Flego, Michela; Ascione, Alessandro; Cianfriglia, Maurizio; Vella, Stefano |
2013 |
2013-01-04 |
COMM-USE |
N |
PMC3565905 |
23289632.0 |
10.1186/1741-7015-11-4 |
grsv06j7 |
0.511772 |
Pizzorno_2019 |
Zhu_X_2015, Martínez_2008 |
| 28 |
Ekins_2015 |
FDA approved drugs as potential Ebola treatments |
Ekins, Sean; Coffee, Megan |
2015 |
2015-03-10 |
COMM-USE |
N |
PMC4358410 |
25789163.0 |
10.12688/f1000research.6164.2 |
8kkihn51 |
0.501843 |
Beigel_2010 |
D’Alessandro_2020, Martínez_2008, Caly_2020 |
| 29 |
Omrani_2015 |
Therapeutic Options for Middle East Respiratory Syndrome Coronavirus (MERS-CoV) Infection: How Close Are We? |
Omrani, Ali S.; Memish, Ziad A. |
2015 |
2015-06-12 |
PMC |
N |
PMC7100761 |
|
10.1007/s40506-015-0048-2 |
h3980atj |
0.496268 |
Beigel_2010, Martínez_2008, Dunning_2014, Jerome_2005 |
Al-Tawfiq_2016 |
| 30 |
McCune_2015 |
Developing and Using Therapeutics for Emerging Infections |
McCune, Jeannine S.; Reynolds, Kellie S. |
2015 |
2015-09-15 |
PMC |
N |
PMC7162320 |
26179402.0 |
10.1002/cpt.183 |
lrmjwur0 |
0.494808 |
|
|
| 31 |
Zhang_2020 |
Current status of potential therapeutic candidates for the COVID-19 crisis |
Zhang, Jiancheng; Xie, Bing; Hashimoto, Kenji |
2020 |
2020-04-22 |
PMC |
Y |
|
|
10.1016/j.bbi.2020.04.046 |
4zmqplz0 |
0.491501 |
Dove_2004, Beigel_2010 |
|
| 32 |
Chaudhuri_2018 |
Innovation and trends in the development and approval of antiviral medicines: 1987–2017 and beyond |
Chaudhuri, Shuvam; Symons, Julian A.; Deval, Jerome |
2018 |
2018-07-31 |
PMC |
N |
PMC7126013 |
29758235.0 |
10.1016/j.antiviral.2018.05.005 |
0ewcptub |
0.489024 |
Dove_2004, Li_C_2019, Beigel_2010, Pizzorno_2019 |
Zhu_X_2015, Flego_2013 |
| 33 |
Wani_2015 |
Ferroquine and its derivatives: New generation of antimalarial agents |
Wani, Waseem A.; Jameel, Ehtesham; Baig, Umair; Mumtazuddin, Syed; Hun, Lee Ting |
2015 |
2015-08-28 |
PMC |
N |
PMC7115395 |
26188909.0 |
10.1016/j.ejmech.2015.07.009 |
ifp7kaj1 |
0.483235 |
Pastuch-Gawołek_2019, Beigel_2010, Dove_2004 |
|
| 34 |
Bayry_2004 |
Intravenous immunoglobulin for infectious diseases: back to the pre-antibiotic and passive prophylaxis era? |
Bayry, Jagadeesh; Lacroix-Desmazes, Sébastien; Kazatchkine, Michel D; Kaveri, Srini V |
2004 |
2004-06-30 |
PMC |
N |
PMC7127229 |
15165745.0 |
10.1016/j.tips.2004.04.002 |
uifm3l2p |
0.483128 |
Li_C_2019, Sousa_2016, Pizzorno_2019 |
Kaufmann_2017 |
| 35 |
Harrington_2010 |
Clinical trials with oncolytic reovirus: Moving beyond phase I into combinations with standard therapeutics |
Harrington, K.J.; Vile, R.G.; Melcher, A.; Chester, J.; Pandha, H.S. |
2010 |
2010-06-30 |
None |
N |
PMC3915505 |
20223697.0 |
10.1016/j.cytogfr.2010.02.006 |
hcqe6xsr |
0.482585 |
|
Martínez_2008, Chen_2019 |
| 36 |
Salata_2017 |
Antiviral activity of cationic amphiphilic drugs |
Salata, Cristiano; Calistri, Arianna; Parolin, Cristina; Baritussio, Aldo; Palù, Giorgio |
2017 |
2017-03-20 |
PMC |
N |
PMC7103695 |
28286997.0 |
10.1080/14787210.2017.1305888 |
05fiqpeg |
0.481980 |
Beigel_2010, Wisskirchen_2014, Pizzorno_2019 |
Lee_C_2019, Al‐Bari_2017, Gwyer_Findlay_2013 |
| 37 |
Beilvert_2012 |
Local siRNA delivery by non-viral vectors |
Beilvert, F.; Mével, M.; Châtin, B.; Pitard, B. |
2012 |
2012-12-31 |
PMC |
N |
PMC7128187 |
|
10.1016/s1773-2247(12)50002-x |
eao31w0i |
0.481206 |
Oliveira_2006 |
Martínez_2008 |
| 38 |
Litterman_2015 |
Small molecules with antiviral activity against the Ebola virus |
Litterman, Nadia; Lipinski, Christopher; Ekins, Sean |
2015 |
2015-02-09 |
COMM-USE |
N |
PMC4335594 |
25713700.0 |
10.12688/f1000research.6120.1 |
69rlh9or |
0.479699 |
Beigel_2010, Ekins_2015 |
Yasuhara-Bell_2010 |
| 39 |
Severa_2019 |
Thymosins in multiple sclerosis and its experimental models: moving from basic to clinical application |
Severa, Martina; Zhang, Jing; Giacomini, Elena; Rizzo, Fabiana; Etna, Marilena Paola; Cruciani, Melania; Garaci, Enrico; Chopp, Michael; Coccia, Eliana Marina |
2019 |
2019-01-31 |
PMC |
N |
PMC7104151 |
30317071.0 |
10.1016/j.msard.2018.09.035 |
lxts00rh |
0.474406 |
|
|
| 40 |
Mahapatra_2020 |
Repurposing Therapeutics for COVID-19: Rapid Prediction of Commercially available drugs through Machine Learning and Docking |
Sovesh Mahapatra; Prathul Nath; Manisha Chatterjee; Neeladrisingha Das; Deepjyoti Kalita; Partha Roy; Soumitra Satapathi |
2020 |
2020-04-07 |
BioRxiv |
Y |
|
|
10.1101/2020.04.05.20054254 |
m0q7rm6z |
0.473943 |
Dove_2004 |
Lv_B_2018, Li_Y_2020, Tang_2020 |
| 41 |
Li_G_2017 |
Current therapy for chronic hepatitis C: The role of direct-acting antivirals |
Li, Guangdi; De Clercq, Erik |
2017 |
2017-06-30 |
PMC |
N |
|
28238877.0 |
10.1016/j.antiviral.2017.02.014 |
xnklc5z2 |
0.470930 |
Martínez_2008, Jerome_2005, Pizzorno_2019, Balicer_2005, Dunning_2014 |
|
| 42 |
Al-Tawfiq_2016 |
Update on therapeutic options for Middle East Respiratory Syndrome Coronavirus (MERS-CoV) |
Al-Tawfiq, Jaffar A.; Memish, Ziad A. |
2016 |
2016-12-24 |
PMC |
N |
PMC7103731 |
27937060.0 |
10.1080/14787210.2017.1271712 |
n4s8dzgp |
0.466401 |
|
Omrani_2015 |
| 43 |
Wiebe_2009 |
Pharmacologic Advances in Canine and Feline Reproduction |
Wiebe, Valerie J.; Howard, James P. |
2009 |
2009-05-31 |
PMC |
N |
PMC7104932 |
19501345.0 |
10.1053/j.tcam.2008.12.004 |
k2dt7h00 |
0.461923 |
Dove_2004 |
Takano_2013 |
| 44 |
Martín_2010 |
Building Cell Selectivity into CPP-Mediated Strategies |
Martín, Irene; Teixidó, Meritxell; Giralt, Ernest |
2010 |
2010-05-14 |
COMM-USE |
N |
PMC4033992 |
27713313.0 |
10.3390/ph3051456 |
fo5naae7 |
0.452833 |
|
Heitz_2009 |
| 45 |
Bekerman_2015 |
Combating emerging viral threats |
Bekerman, Elena; Einav, Shirit |
2015 |
2015-04-16 |
PMC |
N |
PMC4419706 |
25883340.0 |
10.1126/science.aaa3778 |
pxahhwr9 |
0.447538 |
Dove_2004, Li_C_2019, Wisskirchen_2014 |
Schor_2018, García-Serradilla_2019, Gwyer_Findlay_2013, Zilbermintz_2015 |
| 46 |
Kadri_2018 |
Niclosamide, a Drug with Many (Re)purposes |
Kadri, Hachemi; Lambourne, Olivia A.; Mehellou, Youcef |
2018 |
2018-05-08 |
PMC |
N |
PMC7162286 |
29603892.0 |
10.1002/cmdc.201800100 |
95ulbyjk |
0.446330 |
|
|
| 47 |
Mustafa_2018 |
Current treatment options and the role of peptides as potential therapeutic components for Middle East Respiratory Syndrome (MERS): A review |
Mustafa, Sabeena; Balkhy, Hanan; Gabere, Musa N. |
2018 |
2018-02-28 |
PMC |
N |
PMC7102797 |
28864360.0 |
10.1016/j.jiph.2017.08.009 |
r88zb7t4 |
0.446241 |
Li_C_2019, Dove_2004, Beigel_2010, Wisskirchen_2014 |
Omrani_2015, Al-Tawfiq_2016 |
| 48 |
Kim_K_2006 |
Microspheres for Drug Delivery |
Kim, Kyekyoon Kevin; Pack, Daniel W. |
2006 |
2006-01-01 |
PMC |
N |
PMC7122341 |
|
10.1007/978-0-387-25842-3_2 |
yetymjyk |
0.445915 |
Dove_2004 |
Lin_Y_2015 |
| 49 |
Riggs_2019 |
Calf Clinical Model of Cryptosporidiosis for Efficacy Evaluation of Therapeutics |
Riggs, Michael W.; Schaefer, Deborah A. |
2019 |
2019-08-27 |
PMC |
N |
PMC7120472 |
31452167.0 |
10.1007/978-1-4939-9748-0_15 |
n0dtdfec |
0.440040 |
|
Wu_H_2016 |
| 50 |
Donia_2003 |
Marine natural products and their potential applications as anti-infective agents |
Donia, Marwa; Hamann, Mark T |
2003 |
2003-06-30 |
PMC |
N |
PMC7106398 |
12781505.0 |
10.1016/s1473-3099(03)00655-8 |
599vweqe |
0.439281 |
|
Lee_C_2019 |
| 51 |
Elbahesh_2019 |
Response Modifiers: Tweaking the Immune Response Against Influenza A Virus |
Elbahesh, Husni; Gerlach, Thomas; Saletti, Giulietta; Rimmelzwaan, Guus F. |
2019 |
2019-04-12 |
COMM-USE |
N |
PMC6473099 |
31031778.0 |
10.3389/fimmu.2019.00809 |
m2fsrwvw |
0.439209 |
Wisskirchen_2014 |
Kaufmann_2017, Berry_2014 |
| 52 |
Wanve_2018 |
Therapeutic spectrum of interferon‐β in ischemic stroke |
Wanve, Madhuri; Kaur, Harpreet; Sarmah, Deepaneeta; Saraf, Jackson; Pravalika, Kanta; Vats, Kanchan; Kalia, Kiran; Borah, Anupom; Yavagal, Dileep R.; Dave, Kunjan R.; Bhattacharya, Pallab |
2018 |
2018-10-15 |
PMC |
N |
PMC7167007 |
30320448.0 |
10.1002/jnr.24333 |
rkb9z5t9 |
0.439059 |
|
|
| 53 |
Hayden_2013 |
Advances in antivirals for non‐influenza respiratory virus infections |
Hayden, Frederick G. |
2013 |
2013-11-01 |
PMC |
N |
PMC6492651 |
24215380.0 |
10.1111/irv.12173 |
r9kv67we |
0.438223 |
|
Martínez_2008 |
| 54 |
Fear_2007 |
Protease inhibitors and their peptidomimetic derivatives as potential drugs |
Fear, Georgie; Komarnytsky, Slavko; Raskin, Ilya |
2007 |
2007-02-28 |
PMC |
N |
PMC7112583 |
17098288.0 |
10.1016/j.pharmthera.2006.09.001 |
4scnq04v |
0.431752 |
Li_C_2019, Martínez_2008 |
Chen_2019, Zhu_X_2015, Chang_2019 |
| 55 |
Cao_Y_2020 |
Remdesivir for severe acute respiratory syndrome coronavirus 2 causing COVID-19: An evaluation of the evidence |
Cao, Yu-chen; Deng, Qi-xin; Dai, Shi-xue |
2020 |
2020-04-02 |
PMC |
Y |
|
|
10.1016/j.tmaid.2020.101647 |
b518n9dx |
0.431752 |
Beigel_2010 |
|
| 56 |
Zhang_2015 |
A review on recent developments of indole-containing antiviral agents |
Zhang, Ming-Zhi; Chen, Qiong; Yang, Guang-Fu |
2015 |
2015-01-07 |
PMC |
N |
PMC7115707 |
25462257.0 |
10.1016/j.ejmech.2014.10.065 |
rbdhdf6w |
0.429920 |
Dove_2004 |
Liu_A_2012, Chattopadhyay_2009, Serban_2020, Bekut_2018 |
| 57 |
Shameer_2018 |
Rapid Therapeutic Recommendations in the Context of a Global Public Health Crisis using Translational Bioinformatics Approaches: A proof-of-concept study using Nipah Virus Infection |
Khader Shameer; Kipp W. Johnson; Ben Readhead; Benjamin S. Glicksberg; Claire McCallum; Amjesh Revikumar; Jamie S. Hirsch; Kevin Bock; John Chelico; Negin Hajizadeh; Michael Oppenheim; Joel T. Dudley |
2018 |
2018-05-29 |
BioRxiv |
N |
|
|
10.1101/333021 |
quu8c5l7 |
0.428520 |
|
Lv_B_2018, Mahapatra_2020 |
| 58 |
Arendse_2019 |
Novel Therapeutic Approaches Targeting the Renin-Angiotensin System and Associated Peptides in Hypertension and Heart Failure |
Arendse, Lauren B.; Danser, A. H. Jan; Poglitsch, Marko; Touyz, Rhian M.; Burnett, John C.; Llorens-Cortes, Catherine; Ehlers, Mario R.; Sturrock, Edward D. |
2019 |
2019-10-23 |
NONCOMM |
N |
PMC6782023 |
31537750.0 |
10.1124/pr.118.017129 |
gx9urpdo |
0.424559 |
|
|
| 59 |
Prior_2018 |
Recent Reports of Solid-Phase Cyclohexapeptide Synthesis and Applications |
Prior, Allan M.; Hori, Taylor; Fishman, Ashriel; Sun, Dianqing |
2018 |
2018-06-18 |
COMM-USE |
N |
PMC6100019 |
29912160.0 |
10.3390/molecules23061475 |
l1jg9ltr |
0.421390 |
Park_2012, Zoete_2009 |
Chen_2019 |
| 60 |
Sallard_2020 |
Type 1 interferons as a potential treatment against COVID-19 |
Sallard, Erwan; Lescure, François-Xavier; Yazdanpanah, Yazdan; Mentre, France; Peiffer-Smadja, Nathan |
2020 |
2020-06-30 |
PMC |
Y |
|
|
10.1016/j.antiviral.2020.104791 |
a0ribcmv |
0.420548 |
Beigel_2010 |
Martínez_2008 |
| 61 |
Paliwal_2011 |
Neglected Disease – African Sleeping Sickness: Recent Synthetic and Modeling Advances |
Paliwal, Sarvesh K.; Verma, Ankita Narayan; Paliwal, Shailendra |
2011 |
2011-05-10 |
COMM-USE |
N |
PMC3163371 |
21886894.0 |
10.3797/scipharm.1012-08 |
2x7dfl1q |
0.419501 |
|
Wu_H_2016 |
| 62 |
Murgueitio_2012 |
In silico virtual screening approaches for anti-viral drug discovery |
Murgueitio, Manuela S.; Bermudez, Marcel; Mortier, Jérémie; Wolber, Gerhard |
2012 |
2012-11-30 |
PMC |
N |
PMC7105918 |
24990575.0 |
10.1016/j.ddtec.2012.07.009 |
x5bb2sym |
0.410769 |
Dove_2004 |
Kumar_2015, Chiba_2012, Pillaiyar_2020 |
| 63 |
Kramer_2015 |
Antilipidemic Drug Therapy Today and in the Future |
Kramer, Werner |
2015 |
2015-04-24 |
PMC |
N |
PMC7122375 |
26330256.0 |
10.1007/164_2015_15 |
7r35ow4y |
0.410529 |
Bumcrot_2006 |
|
| 64 |
Kutner_2013 |
Use of nitric oxide nanoparticulate platform for the treatment of skin and soft tissue infections |
Kutner, Allison J.; Friedman, Adam J. |
2013 |
2013-05-09 |
PMC |
N |
PMC7169754 |
23661566.0 |
10.1002/wnan.1230 |
lvoy149h |
0.407725 |
Dove_2004 |
|
| 65 |
Rosa_2019 |
Seaweed Secondary Metabolites with Beneficial Health Effects: An Overview of Successes in In Vivo Studies and Clinical Trials |
Rosa, Gonçalo P.; Tavares, Wilson R.; Sousa, Pedro M. C.; Pagès, Aida K.; Seca, Ana M. L.; Pinto, Diana C. G. A. |
2019 |
2019-12-20 |
COMM-USE |
N |
PMC7024274 |
31861879.0 |
10.3390/md18010008 |
mf3ess25 |
0.404846 |
|
|
| 66 |
Pu_J_2019 |
Development of Protein- and Peptide-Based HIV Entry Inhibitors Targeting gp120 or gp41 |
Pu, Jing; Wang, Qian; Xu, Wei; Lu, Lu; Jiang, Shibo |
2019 |
2019-08-01 |
COMM-USE |
N |
PMC6722851 |
31374953.0 |
10.3390/v11080705 |
s4t2eju3 |
0.404304 |
Martínez_2008, Pizzorno_2019 |
Zhu_X_2015, Martínez_2008 |
| 67 |
Veggiani_2019 |
Emerging drug development technologies targeting ubiquitination for cancer therapeutics |
Veggiani, Gianluca; Gerpe, María Carla Rosales; Sidhu, Sachdev S.; Zhang, Wei |
2019 |
2019-07-31 |
PMC |
N |
PMC7112620 |
30851297.0 |
10.1016/j.pharmthera.2019.03.003 |
r4on3lpr |
0.403025 |
|
Edelmann_2011, Chen_2019 |
| 68 |
Ben-Zvi_2011 |
Hydroxychloroquine: From Malaria to Autoimmunity |
Ben-Zvi, Ilan; Kivity, Shaye; Langevitz, Pnina; Shoenfeld, Yehuda |
2011 |
2011-01-08 |
PMC |
N |
PMC7091063 |
21221847.0 |
10.1007/s12016-010-8243-x |
51c22b8w |
0.402209 |
Pastuch-Gawołek_2019 |
Chen_2019 |
| 69 |
García-Serradilla_2019 |
Drug repurposing for new, efficient, broad spectrum antivirals |
García-Serradilla, Moisés; Risco, Cristina; Pacheco, Beatriz |
2019 |
2019-04-15 |
PMC |
N |
PMC7114681 |
30794895.0 |
10.1016/j.virusres.2019.02.011 |
75zgljet |
0.402063 |
Dove_2004 |
Pizzorno_2019, Schor_2018, Mercorelli_2018, Martínez_2008 |
| 70 |
Nguyen_2019 |
GraphDTA: Predicting drug–target binding affinity with graph neural networks |
Thin Nguyen; Hang Le; Thomas P. Quinn; Thuc Le; Svetha Venkatesh |
2019 |
2019-06-27 |
BioRxiv |
N |
|
|
10.1101/684662 |
zult69f2 |
0.399648 |
|
|
| 71 |
Hajitou_2006 |
Vascular Targeting: Recent Advances and Therapeutic Perspectives |
Hajitou, Amin; Pasqualini, Renata; Arap, Wadih |
2006 |
2006-04-30 |
PMC |
N |
|
16546688.0 |
10.1016/j.tcm.2006.01.003 |
yma7alqo |
0.396298 |
|
|
| 72 |
Fedson_2006 |
Pandemic Influenza: A Potential Role for Statins in Treatment and Prophylaxis |
Fedson, David S. |
2006 |
2006-07-15 |
PMC |
N |
PMC7107836 |
16779747.0 |
10.1086/505116 |
q6h46bjn |
0.393066 |
|
Dunning_2014 |
| 73 |
Taylor_2014 |
Discovery of Novel GPVI Receptor Antagonists by Structure-Based Repurposing |
Taylor, Lewis; Vasudevan, Sridhar R.; Jones, Chris I.; Gibbins, Jonathan M.; Churchill, Grant C.; Campbell, R. Duncan; Coxon, Carmen H. |
2014 |
2014-06-27 |
COMM-USE |
N |
PMC4074120 |
24971515.0 |
10.1371/journal.pone.0101209 |
j6ateco7 |
0.391195 |
Ding_2019 |
Chen_2019, Fan_H_2017 |
| 74 |
Hernandez_2018 |
High Throughput and Computational Repurposing for Neglected Diseases |
Hernandez, Helen W.; Soeung, Melinda; Zorn, Kimberley M.; Ashoura, Norah; Mottin, Melina; Andrade, Carolina Horta; Caffrey, Conor R.; de Siqueira-Neto, Jair Lage; Ekins, Sean |
2018 |
2018-12-17 |
PMC |
N |
PMC6792295 |
30560386.0 |
10.1007/s11095-018-2558-3 |
9uyeflgg |
0.388536 |
Dove_2004 |
Lv_B_2018 |
| 75 |
Ganta_2019 |
A review on HCV inhibitors: Significance of non-structural polyproteins |
Ganta, Narayana Murthy; Gedda, Gangaraju; Rathnakar, Bethi; Satyanarayana, Mavurapu; Yamajala, Bhaskar; Ahsan, Mohamed Jawed; Jadav, Surender Singh; Balaraju, Tuniki |
2019 |
2019-02-15 |
PMC |
N |
|
30639895.0 |
10.1016/j.ejmech.2018.12.045 |
19o5az0v |
0.387141 |
Jerome_2005 |
|
| 76 |
Saylor_2009 |
Monoclonal antibody-based therapies for microbial diseases |
Saylor, Carolyn; Dadachova, Ekaterina; Casadevall, Arturo |
2009 |
2009-12-30 |
None |
N |
PMC2810317 |
20006139.0 |
10.1016/j.vaccine.2009.09.105 |
40tq0fa7 |
0.385347 |
Dove_2004 |
Flego_2013 |
| 77 |
Kosinska_2010 |
Therapeutic Vaccination in Chronic Hepatitis B: Preclinical Studies in the Woodchuck |
Kosinska, Anna D.; Zhang, Ejuan; Lu, Mengji; Roggendorf, Michael |
2010 |
2010-09-07 |
COMM-USE |
N |
PMC3003998 |
21188201.0 |
10.1155/2010/817580 |
cgx90xnt |
0.381713 |
|
Choi_2018 |
| 78 |
Moors_2007 |
Orphan drugs: Unmet societal need for non-profitable privately supplied new products |
Moors, Ellen H.M.; Faber, Jan |
2007 |
2007-04-30 |
PMC |
N |
PMC7112095 |
|
10.1016/j.respol.2006.12.006 |
wo20ioz1 |
0.378111 |
|
Senanayake_2020, Bolken_2008, Pillaiyar_2020, Martínez_2008 |
| 79 |
LI_J_2015 |
Anti-inflammatory functions of Houttuynia cordata Thunb. and its compounds: A perspective on its potential role in rheumatoid arthritis |
LI, JUN; ZHAO, FUTAO |
2015 |
2015-04-30 |
PMC |
N |
PMC4487049 |
26170903.0 |
10.3892/etm.2015.2467 |
58yi9c9t |
0.376825 |
Waehler_2007 |
|
| 80 |
Carrasco_1994 |
Picornavirus inhibitors |
Carrasco, Luis |
1994 |
1994-12-31 |
PMC |
N |
|
7533301.0 |
10.1016/0163-7258(94)90040-x |
43zrew96 |
0.375865 |
|
|
| 81 |
Sadikot_2017 |
Nanomedicine for Treatment of Acute Lung Injury and Acute Respiratory Distress Syndrome |
Sadikot, Ruxana T.; Kolanjiyil, Arun V.; Kleinstreuer, Clement; Rubinstein, Israel |
2017 |
2017-06-27 |
NONCOMM |
N |
PMC6945951 |
31988911.0 |
10.1159/000477086 |
27gutwjd |
0.372232 |
|
Sadikot_2012 |
| 82 |
Schein_2019 |
Repurposing approved drugs on the pathway to novel therapies |
Schein, Catherine H. |
2019 |
2019-08-20 |
PMC |
N |
PMC7018532 |
31432544.0 |
10.1002/med.21627 |
zbt4bo4f |
0.372047 |
Fernández‐Oliva_2019, Li_C_2019, Pastuch-Gawołek_2019 |
|
| 83 |
Wainwright_2017 |
Photoantimicrobials—are we afraid of the light? |
Wainwright, Mark; Maisch, Tim; Nonell, Santi; Plaetzer, Kristjan; Almeida, Adelaide; Tegos, George P; Hamblin, Michael R |
2017 |
2017-02-28 |
None |
N |
PMC5280084 |
27884621.0 |
10.1016/s1473-3099(16)30268-7 |
ztwejkes |
0.368982 |
Fernández‐Oliva_2019 |
Peyclit_2019, Rolain_2007 |
| 84 |
Teixeira_2020 |
Nanomedicines for the Delivery of Antimicrobial Peptides (AMPs) |
Teixeira, Maria C.; Carbone, Claudia; Sousa, Maria C.; Espina, Marta; Garcia, Maria L.; Sanchez-Lopez, Elena; Souto, Eliana B. |
2020 |
2020-03-20 |
COMM-USE |
N |
PMC7153398 |
32244858.0 |
10.3390/nano10030560 |
ix5un6c9 |
0.368609 |
Dove_2004, Fernández‐Oliva_2019 |
|
| 85 |
Lin_Y_2015 |
Active Targeted Drug Delivery for Microbes Using Nano-Carriers |
Lin, Yung-Sheng; Lee, Ming-Yuan; Yang, Chih-Hui; Huang, Keng-Shiang |
2015 |
2015-08-23 |
NONCOMM |
N |
PMC4997950 |
25877093.0 |
10.2174/1568026615666150414123157 |
kpcb2vy4 |
0.366863 |
Wisskirchen_2014, Fernández‐Oliva_2019 |
Cojocaru_2020, Schor_2018 |
| 86 |
Kuo_R_2013 |
Strategies to develop antivirals against enterovirus 71 |
Kuo, Rei-Lin; Shih, Shin-Ru |
2013 |
2013-01-22 |
COMM-USE |
N |
PMC3614426 |
23339605.0 |
10.1186/1743-422x-10-28 |
nj4p03cr |
0.366496 |
Jerome_2005 |
Hsieh_2010 |
| 87 |
Whitehead_2009 |
Knocking down barriers: advances in siRNA delivery |
Whitehead, Kathryn A.; Langer, Robert; Anderson, Daniel G. |
2009 |
2009-01-01 |
PMC |
N |
PMC7097568 |
19180106.0 |
10.1038/nrd2742 |
if46jycd |
0.364998 |
Dove_2004, Martínez_2008 |
Martínez_2008, Beilvert_2012, Manjunath_2006 |
| 88 |
Dhanani_2016 |
Fundamentals of aerosol therapy in critical care |
Dhanani, Jayesh; Fraser, John F.; Chan, Hak-Kim; Rello, Jordi; Cohen, Jeremy; Roberts, Jason A. |
2016 |
2016-10-07 |
COMM-USE |
N |
PMC5054555 |
27716346.0 |
10.1186/s13054-016-1448-5 |
gsnjlhjd |
0.358177 |
Velkov_2015 |
Velkov_2015 |
| 89 |
Wang_2019 |
Development of Small-Molecule Inhibitors Against Zika Virus Infection |
Wang, Lili; Liang, Ruiying; Gao, Yaning; Li, Yanbai; Deng, Xiaoqian; Xiang, Rong; Zhang, Yina; Ying, Tianlei; Jiang, Shibo; Yu, Fei |
2019 |
2019-12-06 |
COMM-USE |
N |
PMC6909824 |
31866959.0 |
10.3389/fmicb.2019.02725 |
lwt5nmf2 |
0.352072 |
|
D’Alessandro_2020, Martínez_2008 |
| 90 |
Salazar_2017 |
Antibody therapies for the prevention and treatment of viral infections |
Salazar, Georgina; Zhang, Ningyan; Fu, Tong-Ming; An, Zhiqiang |
2017 |
2017-07-10 |
COMM-USE |
N |
PMC5627241 |
29263875.0 |
10.1038/s41541-017-0019-3 |
0gfxy9z6 |
0.351954 |
Wisskirchen_2014 |
Kaufmann_2017, Martínez_2008, Flego_2013 |
| 91 |
Touret_2020 |
Of chloroquine and COVID-19 |
Touret, Franck; de Lamballerie, Xavier |
2020 |
2020-05-31 |
None |
Y |
PMC7132364 |
32147496.0 |
10.1016/j.antiviral.2020.104762 |
y7lrp0gc |
0.351577 |
Beigel_2010 |
Wu_H_2016 |
| 92 |
Mirza_2019 |
Perspectives towards antiviral drug discovery against Ebola virus |
Mirza, Muhammad Usman; Vanmeert, Michiel; Ali, Amjad; Iman, Kanzal; Froeyen, Matheus; Idrees, Muhammad |
2019 |
2019-09-30 |
PMC |
N |
PMC7166701 |
30431654.0 |
10.1002/jmv.25357 |
zo1465i3 |
0.346899 |
Dove_2004 |
|
| 93 |
Choudhary_2020 |
Potential use of hydroxychloroquine, ivermectin and azithromycin drugs in fighting COVID-19: trends, scope and relevance |
Choudhary, Renuka; Sharma, Anil K.; Choudhary, Renuka |
2020 |
2020-04-22 |
PMC |
Y |
|
|
10.1016/j.nmni.2020.100684 |
tqj2s9qf |
0.343211 |
|
|
| 94 |
Akinc_2008 |
A combinatorial library of lipid-like materials for delivery of RNAi therapeutics |
Akinc, Akin; Zumbuehl, Andreas; Goldberg, Michael; Leshchiner, Elizaveta S; Busini, Valentina; Hossain, Naushad; Bacallado, Sergio A; Nguyen, David N; Fuller, Jason; Alvarez, Rene; Borodovsky, Anna; Borland, Todd; Constien, Rainer; de Fougerolles, Antonin; Dorkin, J Robert; Jayaprakash, K Narayanannair; Jayaraman, Muthusamy; John, Matthias; Koteliansky, Victor; Manoharan, Muthiah; Nechev, Lubomir; Qin, June; Racie, Timothy; Raitcheva, Denitza; Rajeev, Kallanthottathil G; Sah, Dinah W Y; Soutschek, Jürgen; Toudjarska, Ivanka; Vornlocher, Hans-Peter; Zimmermann, Tracy S; Langer, Robert; Anderson, Daniel G |
2008 |
2008-04-27 |
PMC |
N |
PMC3014085 |
18438401.0 |
10.1038/nbt1402 |
26n0ku7d |
0.342302 |
|
|
| 95 |
Gao_K_2008 |
Non-viral Methods for siRNA Delivery |
Gao, Kun; Huang, Leaf |
2008 |
2008-12-30 |
PMC |
N |
PMC2692493 |
19115957.0 |
10.1021/mp800134q |
5kzb4ynl |
0.340907 |
|
Beilvert_2012 |
| 96 |
Chattopadhyay_2015 |
Chapter 8 Validation of Antiviral Potential of Herbal Ethnomedicine |
Chattopadhyay, Debprasad; Ojha, Durbadal; Mondal, Supriya; Goswami, Debayan |
2015 |
2015-12-31 |
PMC |
N |
PMC7150199 |
|
10.1016/b978-0-12-800874-4.00008-8 |
a5wlqvsd |
0.340717 |
Dove_2004, Jerome_2005 |
Bekut_2018 |
| 97 |
Jefferson_2009 |
Antivirals for the common cold |
Jefferson, Tom |
2009 |
2009-11-10 |
PMC |
N |
PMC7123222 |
|
10.1007/978-3-7643-9912-2_10 |
t8jzsrb7 |
0.338838 |
|
Peyclit_2019, Wu_H_2016 |
| 98 |
Poissy_2016 |
La modulation de la signature transcriptomique de l’hôte infecté : une nouvelle stratégie thérapeutique dans les viroses graves ? Exemple de la grippe |
Poissy, J.; Terrier, O.; Lina, B.; Textoris, J.; Rosa-Calatrava, M. |
2016 |
2016-04-07 |
PMC |
N |
PMC7117810 |
|
10.1007/s13546-016-1188-1 |
ly68q5z0 |
0.338675 |
Pizzorno_2019 |
McDonagh_2015 |
| 99 |
da_Cunha_2017 |
The next generation of antimicrobial peptides (AMPs) as molecular therapeutic tools for the treatment of diseases with social and economic impacts |
da Cunha, Nicolau B.; Cobacho, Nicole B.; Viana, Juliane F.C.; Lima, Loiane A.; Sampaio, Kamila B.O.; Dohms, Stephan S.M.; Ferreira, Arthur C.R.; de la Fuente-Núñez, César; Costa, Fabrício F.; Franco, Octávio L.; Dias, Simoni C. |
2017 |
2017-02-28 |
PMC |
N |
|
27890668.0 |
10.1016/j.drudis.2016.10.017 |
ogu1gmcb |
0.335907 |
|
Esfandiyari_2019, Schor_2018, Lee_C_2019, Ahmed_2019 |
| 100 |
Dunning_2014 |
Antiviral combinations for severe influenza |
Dunning, Jake; Baillie, J Kenneth; Cao, Bin; Hayden, Frederick G |
2014 |
2014-12-31 |
None |
N |
PMC7164787 |
25213733.0 |
10.1016/s1473-3099(14)70821-7 |
vz1tfnus |
0.332436 |
|
Perwitasari_2016 |
| 101 |
Aslesh_2018 |
Skipping Multiple Exons to Treat DMD—Promises and Challenges |
Aslesh, Tejal; Maruyama, Rika; Yokota, Toshifumi |
2018 |
2018-01-02 |
COMM-USE |
N |
PMC5874658 |
29301272.0 |
10.3390/biomedicines6010001 |
mtmfh3uy |
0.332373 |
|
|
| 102 |
Russell_2007 |
Viruses as anticancer drugs |
Russell, Stephen J.; Peng, Kah-Whye |
2007 |
2007-07-01 |
PMC |
N |
PMC3125087 |
17573126.0 |
10.1016/j.tips.2007.05.005 |
pl6uf13v |
0.332151 |
Li_C_2019, Wisskirchen_2014, Dove_2004 |
Kaufman_2015 |
| 103 |
Kalia_2007 |
New concepts in antimalarial use and mode of action in dermatology |
Kalia, Sunil; Dutz, Jan P |
2007 |
2007-10-25 |
PMC |
N |
PMC7163426 |
17970883.0 |
10.1111/j.1529-8019.2007.00131.x |
08j87r2u |
0.331599 |
|
|
| 104 |
Ramana_2014 |
Targeting strategies for delivery of anti-HIV drugs |
Ramana, Lakshmi Narashimhan; Anand, Appakkudal R.; Sethuraman, Swaminathan; Krishnan, Uma Maheswari |
2014 |
2014-10-28 |
PMC |
N |
PMC7114626 |
25119469.0 |
10.1016/j.jconrel.2014.08.003 |
hbv49e01 |
0.329526 |
Martínez_2008, Wisskirchen_2014, Pizzorno_2019 |
Martínez_2008, Zhu_X_2015, Kaufmann_2017 |
| 105 |
Edelmann_2011 |
Pharmacological targets in the ubiquitin system offer new ways of treating cancer, neurodegenerative disorders and infectious diseases |
Edelmann, Mariola J.; Nicholson, Benjamin; Kessler, Benedikt M. |
2011 |
2011-11-23 |
NONCOMM |
N |
PMC3219211 |
22088887.0 |
10.1017/s1462399411002031 |
o44dtozb |
0.327689 |
|
Chen_2019, Veggiani_2019 |
| 106 |
Wu_K_2010 |
Developments towards antiviral therapies against enterovirus 71 |
Wu, Kan X.; Ng, Mary M.-L.; Chu, Justin J.H. |
2010 |
2010-12-31 |
PMC |
N |
PMC7108380 |
20974282.0 |
10.1016/j.drudis.2010.10.008 |
g7izz5y5 |
0.327689 |
|
Martínez_2008, Bossart_2007 |
| 107 |
Lysik_2003 |
Innovations in Oligonucleotide Drug Delivery |
Lysik, Melanie A.; Wu-Pong, Susanna |
2003 |
2003-08-31 |
PMC |
N |
PMC7094321 |
12884243.0 |
10.1002/jps.10399 |
3l4eaaol |
0.327472 |
Dove_2004, Oliveira_2006 |
Martínez_2008 |
| 108 |
Feng_2018 |
Addressing the selectivity and toxicity of antiviral nucleosides |
Feng, Joy Y |
2018 |
2018-03-13 |
NONCOMM |
N |
PMC5890540 |
29534607.0 |
10.1177/2040206618758524 |
uajl5wyk |
0.326403 |
Jerome_2005 |
Martínez_2008, Zhu_X_2015, Al‐Bari_2017 |
| 109 |
Ancheeva_2018 |
Anti-infective Compounds from Marine Organisms |
Ancheeva, Elena; El-Neketi, Mona; Daletos, Georgios; Ebrahim, Weaam; Song, Weiguo; Lin, Wenhan; Proksch, Peter |
2018 |
2018-02-02 |
PMC |
N |
PMC7123853 |
|
10.1007/978-3-319-69075-9_3 |
4awqfduk |
0.325305 |
|
Donia_2003 |
| 110 |
Ortiz_2015 |
Scorpion venom components as potential candidates for drug development |
Ortiz, Ernesto; Gurrola, Georgina B.; Schwartz, Elisabeth Ferroni; Possani, Lourival D. |
2015 |
2015-01-31 |
PMC |
N |
PMC7130864 |
25432067.0 |
10.1016/j.toxicon.2014.11.233 |
8bbf0qpy |
0.324343 |
Dove_2004 |
Harrison_2014 |
| 111 |
Kevin_2009 |
Polyether ionophores: broad-spectrum and promising biologically active molecules for the control of drug-resistant bacteria and parasites |
Kevin, Dion A; Meujo, Damaris AF; Hamann, Mark T |
2009 |
2009-02-01 |
PMC |
N |
PMC4896753 |
23480512.0 |
10.1517/17460440802661443 |
yub11mys |
0.322767 |
Fernández‐Oliva_2019 |
Lee_C_2019 |
| 112 |
Galasiti_Kankanamalage_2017 |
Structure-Based Exploration and Exploitation of the S(4) Subsite of Norovirus 3CL Protease in the Design of Potent and Permeable Inhibitors |
Galasiti Kankanamalage, Anushka C.; Kim, Yunjeong; Rathnayake, Athri D.; Damalanka, Vishnu C.; Weerawarna, Pathum M.; Doyle, Sean T.; Alsoudi, Amer F.; Padmasankha Dissanayake, D. M.; Lushington, Gerald H.; Mehzabeen, Nurjahan; Battaile, Kevin P.; Lovell, Scott; Chang, Kyeong-Ok; Groutas, William C. |
2017 |
2017-01-01 |
PMC |
N |
PMC5501333 |
27914364.0 |
10.1016/j.ejmech.2016.11.027 |
plbhi112 |
0.322491 |
Dove_2004 |
Kankanamalage_2015, Galasiti_Kankanamalage_2018 |
| 113 |
Lai_K_2014 |
Human Ebola virus infection in West Africa: a review of available therapeutic agents that target different steps of the life cycle of Ebola virus |
Lai, Kang Yiu; Ng, Wing Yiu George; Cheng, Fan Fanny |
2014 |
2014-11-28 |
COMM-USE |
N |
PMC4334593 |
25699183.0 |
10.1186/2049-9957-3-43 |
f089bs8r |
0.318469 |
Dove_2004 |
|
| 114 |
Ekins_2016 |
Open drug discovery for the Zika virus |
Ekins, Sean; Mietchen, Daniel; Coffee, Megan; Stratton, Thomas P; Freundlich, Joel S; Freitas-Junior, Lucio; Muratov, Eugene; Siqueira-Neto, Jair; Williams, Antony J; Andrade, Carolina |
2016 |
2016-02-09 |
COMM-USE |
N |
PMC4841202 |
27134728.0 |
10.12688/f1000research.8013.1 |
3967e2da |
0.318136 |
|
Lv_B_2018 |
| 115 |
Pastuch-Gawołek_2019 |
Selected nucleos(t)ide-based prescribed drugs and their multi-target activity |
Pastuch-Gawołek, Gabriela; Gillner, Danuta; Król, Ewelina; Walczak, Krzysztof; Wandzik, Ilona |
2019 |
2019-12-15 |
PMC |
N |
|
31634460.0 |
10.1016/j.ejphar.2019.172747 |
9oj6m3df |
0.318122 |
Li_C_2019, Beigel_2010 |
|
| 116 |
Bogoyevitch_2008 |
Inhibitors of c-Jun N-terminal kinases—JuNK no more? |
Bogoyevitch, Marie A.; Arthur, Peter G. |
2008 |
2008-01-31 |
PMC |
N |
|
17964301.0 |
10.1016/j.bbapap.2007.09.013 |
ivt25ghy |
0.317747 |
|
Chen_2019 |
| 117 |
Harrison_2014 |
Antimicrobial peptides from scorpion venoms |
Harrison, Patrick L.; Abdel-Rahman, Mohamed A.; Miller, Keith; Strong, Peter N. |
2014 |
2014-09-15 |
None |
N |
PMC7111748 |
24951876.0 |
10.1016/j.toxicon.2014.06.006 |
d7shmb2o |
0.315960 |
|
Ortiz_2015, Lee_C_2019, Esfandiyari_2019 |
| 118 |
Rian_2020 |
Mechanistic modeling of the SARS-CoV-2 disease map |
Kinza Rian; Marina Esteban-Medina; Marta R Hidalgo; Cankut Cubuk; Matias M Falco; Carlos Loucera; Devrim Gunyel; Marek Ostaszewski; Maria Pena-Chilet; Joaquin Dopazo |
2020 |
2020-04-12 |
BioRxiv |
Y |
|
|
10.1101/2020.04.12.025577 |
0dpzat5z |
0.313870 |
|
Adhikari_2017 |
| 119 |
Goldenberg_2008 |
Strategies for the Identification of novel inhibitors of deubiquitinating enzymes |
Goldenberg, Seth J; McDermott, Jeffrey L; Butt, Tauseef R; Mattern, Michael R; Nicholson, Benjamin |
2008 |
2008-09-19 |
PMC |
N |
PMC3061546 |
18793145.0 |
10.1042/bst0360828 |
r1xxiy0v |
0.313057 |
|
|
| 120 |
Debing_2014 |
Antiviral strategies for hepatitis E virus |
Debing, Yannick; Neyts, Johan |
2014 |
2014-02-28 |
PMC |
N |
PMC7113752 |
24374149.0 |
10.1016/j.antiviral.2013.12.005 |
n0acj460 |
0.309431 |
Jerome_2005, Wisskirchen_2014 |
|
| 121 |
Makara_2005 |
Improving success rates for lead generation using affinity binding technologies |
Makara, Gergely M; Athanasopoulos, John |
2005 |
2005-12-31 |
PMC |
N |
PMC7126921 |
16257522.0 |
10.1016/j.copbio.2005.10.007 |
g60iybhk |
0.308988 |
Park_2012 |
Chiba_2012, Mitchell_2011, Kumar_2015 |
| 122 |
Lin_L_2014 |
Antiviral Natural Products and Herbal Medicines |
Lin, Liang-Tzung; Hsu, Wen-Chan; Lin, Chun-Ching |
2014 |
2014-03-31 |
PMC |
N |
PMC4032839 |
24872930.0 |
10.4103/2225-4110.124335 |
ut71y7sd |
0.307701 |
Dove_2004 |
Chattopadhyay_2015, Mukherjee_2019, D’Alessandro_2020 |
| 123 |
Haasnoot_2009 |
Nucleic Acids-Based Therapeutics in the Battle Against Pathogenic Viruses |
Haasnoot, Joost; Berkhout, Ben |
2009 |
2009-01-01 |
PMC |
N |
PMC7119910 |
19048203.0 |
10.1007/978-3-540-79086-0_9 |
oncx2myt |
0.307699 |
|
|
| 124 |
Niu_B_2017 |
Small molecular floribundiquinone B derived from medicinal plants inhibits acetylcholinesterase activity |
Niu, Bing; Zhang, Mengying; Du, Pu; Jiang, Li; Qin, Rui; Su, Qiang; Chen, Fuxue; Du, Dongshu; Shu, Yilai; Chou, Kuo-Chen |
2017 |
2017-07-11 |
COMM-USE |
N |
PMC5593632 |
28915661.0 |
10.18632/oncotarget.19169 |
moln6ues |
0.305697 |
|
|
| 125 |
Ulanova_2012 |
The Future of Antisense Oligonucleotides in the Treatment of Respiratory Diseases |
Ulanova, Marina; Schreiber, Alan D.; Befus, A. Dean |
2012 |
2012-08-13 |
PMC |
N |
PMC7100773 |
16573347.0 |
10.2165/00063030-200620010-00001 |
z103k5zn |
0.305652 |
|
Chen_2019 |
| 126 |
Biot_2011 |
The antimalarial ferroquine: from bench to clinic |
Biot, C.; Nosten, F.; Fraisse, L.; Ter-Minassian, D.; Khalife, J.; Dive, D. |
2011 |
2011-08-15 |
COMM-USE |
N |
PMC3671469 |
21894260.0 |
10.1051/parasite/2011183207 |
oean0n3k |
0.304676 |
Touret_2020 |
Ben-Zvi_2011, Lusvarghi_2016 |
| 127 |
Marrugal-Lorenzo_2019 |
Repositioning salicylanilide anthelmintic drugs to treat adenovirus infections |
Marrugal-Lorenzo, José A.; Serna-Gallego, Ana; Berastegui-Cabrera, Judith; Pachón, Jerónimo; Sánchez-Céspedes, Javier |
2019 |
2019-01-09 |
COMM-USE |
N |
PMC6327057 |
30626902.0 |
10.1038/s41598-018-37290-3 |
xty16m8w |
0.304141 |
Li_C_2019, Martínez_2008, Sousa_2016 |
|